Hawkins, KE;
Duchen, M;
(2019)
'Modelling mitochondrial dysfunction in Alzheimer's disease using human induced pluripotent stem cells.
[Review].
World Journal of Stem Cells
, 11
(5)
pp. 236-253.
10.4252/wjsc.v11.i5.236.
Preview |
Text
DuchenWJSC-11-236.pdf - Published Version Download (1MB) | Preview |
Abstract
Alzheimer’s disease (AD) is the most common form of dementia. To date, only five pharmacological agents have been approved by the Food and Drug Administration for clinical use in AD, all of which target the symptoms of the disease rather than the cause. Increasing our understanding of the underlying pathophysiology of AD will facilitate the development of new therapeutic strategies. Over the years, the major hypotheses of AD etiology have focused on deposition of amyloid beta and mitochondrial dysfunction. In this review we highlight the potential of experimental model systems based on human induced pluripotent stem cells (iPSCs) to provide novel insights into the cellular pathophysiology underlying neurodegeneration in AD. Whilst Down syndrome and familial AD iPSC models faithfully reproduce features of AD such as accumulation of Aβ and tau, oxidative stress and mitochondrial dysfunction, sporadic AD is much more difficult to model in this way due to its complex etiology. Nevertheless, iPSC-based modelling of AD has provided invaluable insights into the underlying pathophysiology of the disease, and has a huge potential for use as a platform for drug discovery.
Type: | Article |
---|---|
Title: | 'Modelling mitochondrial dysfunction in Alzheimer's disease using human induced pluripotent stem cells |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.4252/wjsc.v11.i5.236 |
Publisher version: | https://doi.org/10.4252/wjsc.v11.i5.236 |
Language: | English |
Additional information: | This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licen ses/by-nc/4.0/ |
Keywords: | Induced pluripotent stem cells; Alzheimer’s disease; Mitochondria |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > Div of Biosciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > Div of Biosciences > Cell and Developmental Biology |
URI: | https://discovery.ucl.ac.uk/id/eprint/10076806 |
Archive Staff Only
View Item |